AVEXTRA
Avextra is a pharmaceutical company that also offers manufacturing services for cannabis products. Their solutions provide medical professionals, patients, and communities with secure, standardized therapeutic options. By practicing plant-based medicine, they want to maximize this old medicinal plant's therapeutic potential for the benefit of patients all around the world.
AVEXTRA
Social Links:
Industry:
Manufacturing
Founded:
2018-10-01
Address:
Bensheim, Hessen, Germany
Country:
Germany
Website Url:
http://www.avextra.com
Total Employee:
51+
Status:
Active
Total Funding:
37 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics Font Awesome Global Site Tag
Similar Organizations
Advanced Navigation
Advanced Navigation creates AI-powered navigation systems and robotics technologies for use in the air, land, sea, and space.
AnHeart Therapeutics
AnHeart Therapeutics is a developer of innovative pharmaceutical products.
AskGene Pharma
AskGene Pharma is a pharmaceuticals company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company.
Delft Advanced Biorenewables
Uses a proprietary separation / fermentation technology that intensifies biobased chemical/fuel production to produce more for less costs
ForwardX Robotics
ForwardX Robotics specializes in R&D of computer vision robots that apply to consumer and business products.
Lenoss Medical
Lenoss Medical manufacturer of surgical and medical instrument.
SPARK Microsystems
SPARK Microsystems is the enabling wireless technology of the future.
NEOGAP Therapeutics
NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.avextra.com Semrush global rank: 7.08 M Semrush visits lastest month: 893
- Host name: h3008778.stratoserver.net
- IP address: 85.214.86.56
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
More informations about "Avextra"
Avextra | Cannabisbasierte Arzneimittel made in Germany
Avextra stands for expertise & innovation in cannabis-based medicinal products. Learn more about quality from Germany in medical cannabis.See details»
Avextra | Cannabisbasierte Arzneimittel made in Germany
Avextra è esperienza e innovazione nei prodotti medicinali a base di cannabis. Qualità dalla Germania nella cannabis terapeutica.See details»
Avextra - Crunchbase Company Profile & Funding
Avextra is a pharmaceutical company that also offers manufacturing services for cannabis products. Their solutions provide medical professionals, patients, and communities with …See details»
Avextra - Company Profile - Tracxn
Oct 20, 2024 Avextra - Provider of research & development services for medicinal cannabis products. Raised a total funding of $48.1M over 4 rounds from 2 investors.See details»
Avextra Pharma GmbH | VentureRadar
Avextra Pharma GmbH specializes in the development and production of cannabis-based medicines. With over 75 years of experience in plant-based pharmaceuticals, the company …See details»
Avextra Pharma GmbH - Drug pipelines, Patents, Clinical trials
Explore Avextra Pharma GmbH with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, Drug:Cannabinoids.See details»
Avextra Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Avextra. Use the PitchBook Platform to explore the full profile.See details»
Avextra.com - Overview, News & Similar companies - ZoomInfo
View Avextra.com (www.avextra.com) location in Berlin, Germany , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Avextra - LinkedIn
Avextra | 1,730 followers on LinkedIn. Our vision: the leading European Producer of Medicinal Cannabis products. Improving the lives of millions of people. | Our Vision: To understand and …See details»
Press Release Distribution and Management - GlobeNewswire
Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world patient data …See details»
Investor Relations - Cannabisbasierte Arzneimittel von Avextra
European Growth Opportunity Over the last four years, Avextra has built one of the only vertically integrated EU operations from genetic selection and cultivation to sales and distribution. By …See details»
Avextra successfully concludes follow-on capital raise - CannabizEU
Feb 8, 2024 The medical cannabis business in Europe is expanding quickly; by 2030, revenues are expected to surpass EUR 20 billion. Avextra is well-positioned to take advantage of this …See details»
Avextra Successfully Exports Oil-Based Cannabis Medicines to the …
Avextra successfully exported EU-GMP standardised cannabis extracts manufactured in its German facility to its distribution partner in the United Kingdom Export is a significant …See details»
Avextra Unveils its Alliance for Evidence - mg Magazine
Oct 23, 2023 BENSHEIM, Germany — Avextra AG, a leading European vertically-integrated manufacturer of cannabis-based medicines (CBMs) located in Germany, is proud to unveil the …See details»
Investee Company Update: Avextra - tools.eurolandir.com
May 17, 2023 Avextra is one of only three companies approved to import cannabis medicines into the country. In Italy over 70% of the market for cannabis-based medicines is extracts and …See details»
Avextra Portugal Unveils Advanced Breeding Program to Develop ...
Lisbon, Portugal, November 20, 2024 — Avextra Portugal is excited to announce that its innovative in-house breeding program is now operational. The goal of the program is to …See details»
Avextra AG Announces Closing of EU 17 Million Capital Raise
Mar 15, 2023 Avextra announces the closing of its EU 17 Million Convertible Loan Note (“CLN”) bridge capital raise. The CLN will automatically swap into equity at the next capital round …See details»
Cannabidiol - Avextra - AdisInsight
An oral cannabinoid formulation is being developed by Avextra for the treatment of amyotrophic lateral sclerosis, Alzheimer’s disease and Parkinson’s Disease.See details»
Produkte - Cannabisbasierte Arzneimittel von Avextra
Chargensuche Unser umfangreiches Produktportfolio zeichnet sich durch Rezepturen aus, die strengsten pharmazeutischen Standards entsprechen. Alle Produkte werden in der 10.000 m² …See details»